☆ 4.3 Article

A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

ERJ OPEN RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Public health impact of covid-19 vaccines in the United States: observational study

Amitabh Bipin Suthar et al.

Summary: Increasing vaccination coverage was associated with lower rates of population level covid-19 mortality and incidence in the US. Higher vaccination coverage levels were linked to reduced mortality and incidence rates during the eras of alpha and delta variant predominance.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy

Giuseppe Murdaca et al.

Summary: IL-33 is an important cytokine involved in type-2 immunity and allergic airway disease. It plays a significant role in both innate and adaptive immune responses in mucosal organs, particularly in lung epithelial cells. Increased release of IL-33 during respiratory virus infections contributes to pro-inflammatory effects and exacerbates symptoms of chronic respiratory diseases. Understanding the pathogenic and prognostic involvement of IL-33 in respiratory viral infections, including the recent SARS-CoV-2 pandemic, is crucial for developing targeted therapies to improve clinical outcomes.

BIOMEDICINES (2022)

Add to Collection

Article Multidisciplinary Sciences

Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021

Jeffrey Lazarus et al.

Summary: Despite the availability of effective vaccines, the COVID-19 pandemic continues to impact daily life. Vaccine hesitancy is influenced by mistrust in vaccine safety and science, skepticism about efficacy, and resistance to required proof of vaccination.

NATURE COMMUNICATIONS (2022)

Add to Collection

Meeting Abstract Respiratory System

Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

I. C. Scott et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Meeting Abstract Respiratory System

Oxidised IL-33 signals via RAGE/EGFR to drive a COPD-associated phenotype

S. Strickson et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Critical Care Medicine

Tissue-Specific Immunopathology in Fatal COVID-19

David A. Dorward et al.

Summary: In fatal COVID-19 cases, abnormal immune responses were found primarily in the lung and reticuloendothelial system, which were not clearly associated with the virus. Tissue-specific immunopathology in COVID-19 implicates a significant role of immune-mediated, virus-independent mechanisms in severe disease.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Critical Care Medicine

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Ivan O. Rosas et al.

Summary: In patients with severe COVID-19 pneumonia, tocilizumab plus remdesivir did not reduce the time to hospital discharge or readiness for discharge compared to placebo plus remdesivir by day 28.

INTENSIVE CARE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Potential health and economic impacts of dexamethasone treatment for patients with COVID-19

Ricardo Aguas et al.

Summary: The study estimated that the global rollout of dexamethasone could potentially save around 650,000 lives, but its impact might be halved in settings with limited access to oxygen therapies.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Medical Laboratory Technology

Biomarkers for Prognosis and Treatment Response in COVID-19 Patients

Giulia Bivona et al.

Summary: Studies have shown that the levels of CRP and interleukin-6 are associated with disease severity in COVID-19 infections, but their clinical utility as biomarkers has not been proven.

ANNALS OF LABORATORY MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding

Sofija Sekulic Markovic et al.

Summary: The study highlights the significant correlation of increased IL-33 with disease severity in COVID-19 patients, especially in the advanced stage, where IL-33 facilitates lung inflammation by inducing proinflammatory cytokines. IL-33 may serve as a promising marker and therapeutic target in COVID-19.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. A. Madhi et al.

Summary: The ChAdOx1 nCoV-19 vaccine did not provide significant protection against mild-to-moderate Covid-19 caused by the B.1.351 variant, with an efficacy of 10.4%. The incidence of serious adverse events was balanced between the vaccine and placebo groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Anesthesiology

Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives

Alan D. Kaye et al.

Summary: The COVID-19 pandemic has had a significant financial impact on international hospitals and healthcare facilities, causing them to face major financial challenges. It has also exposed deficiencies in pandemic preparedness in healthcare institutions globally, prompting the development of new essential plans.

BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals

Michal A. Stanczak et al.

Summary: The study suggests a potential association between IL-33 production and SARS-CoV-2 infection, and its correlation with CD4(+) T cell activation, antibody titers, and disease severity.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection

Marta Sanchez-Marteles et al.

Summary: The study found that the changes in serum sST2 concentration in COVID-19 patients were closely related to patient prognosis, and a concentration above 58.9 ng/mL could predict whether patients would be admitted to the ICU or die. This suggests that early measurement of sST2 helps identify high-risk patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Medicine, Research & Experimental

ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

Tom Wilkinson et al.

TRIALS (2020)

Add to Collection

Article Rheumatology

Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?

Gaetano Zizzo et al.

LANCET RHEUMATOLOGY (2020)

Add to Collection

Article Respiratory System

Inflammatory phenotyping predicts clinical outcome in COVID-19

H. Burke et al.

RESPIRATORY RESEARCH (2020)

Add to Collection

Review Immunology

IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily

Agata Gabryelska et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Meeting Abstract Respiratory System

Novel assays to measure forms of interleukin-33 in the circulation and airway mucosa

Ian Christopher Scott et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Oncology

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis

J. C. Trone et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Review Immunology

IL-33: biological properties, functions, and roles in airway disease

Li Yin Drake et al.

IMMUNOLOGICAL REVIEWS (2017)

Add to Collection

Article Immunology

Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases

Jing Zhao et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Biology of ST2: The International ST2 Consensus Panel

Domingo A. Pascual-Figal et al.

AMERICAN JOURNAL OF CARDIOLOGY (2015)

Add to Collection

Review Immunology

Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation

Ari B. Molofsky et al.

IMMUNITY (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.